THERACELL ADVANCED BIOTECHNOLOGY (Belgium) SRL
1.6 FTETHERACELL ADVANCED BIOTECHNOLOGY (Belgium) reported total assets of 327,833 € at the end of the 2022 financial year (annual accounts filed with the NBB on 14 Jul 2023), with 1.6 full-time equivalent.
The score of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2020 → 2022: Total assets +52 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
- Year ended 31 Dec 2020filed on 30 Sep 2021
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s financial analysis
- Solvency-54.6%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)
1 active director(s) in the register.
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s shareholders and holdings →THERACELL ADVANCED BIOTECHNOLOGY (Belgium)'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0731.712.273
- VAT number
- BE0731712273
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 30 Jul 2019
- Registered office
- 6900 Marche-en-Famenne
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2022 · filed on 14 Jul 2023
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
THERACELL ADVANCED BIOTECHNOLOGY (Belgium) (SRL) has been based in Marche-en-Famenne since 2019, active in: research and experimental development on other natural sciences and engineering. For 2022, it reports a net loss of 128,310 € and equity of −179,076 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to THERACELL ADVANCED BIOTECHNOLOGY (Belgium)
Companies in the same business, of comparable size and area, outside its group.
- Hugin Mugin Research Research and experimental development on natural sciences and engineering Antwerp · balance sheet 567,097 €
- Hans de Vilder - Clinical Research Consultancy Research and experimental development on natural sciences and engineering Genk · balance sheet 267,868 €
- CRz Services Research and experimental development on natural sciences and engineering Spa · balance sheet 251,152 €
- IPM Impact Research and experimental development on natural sciences and engineering Hasselt · balance sheet 315,364 €
- Asylia Diagnostics Research and experimental development on natural sciences and engineering Leuven · balance sheet 552,090 €
- DESiRE-consulting Research and experimental development on natural sciences and engineering Gesves · balance sheet 286,345 €
- NasaPharm Research and experimental development on natural sciences and engineering Blegny · balance sheet 606,267 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
Frequently asked questions about THERACELL ADVANCED BIOTECHNOLOGY (Belgium)
What is the revenue of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
THERACELL ADVANCED BIOTECHNOLOGY (Belgium) files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
In Belgium, the VAT number is the company number prefixed with BE: BE0731712273 for THERACELL ADVANCED BIOTECHNOLOGY (Belgium), if the company is VAT-registered. Its company number (CBE) is 0731.712.273.
Where is the registered office of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
According to the CBE register, the registered office of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is in 6900 Marche-en-Famenne.
What is the equity of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
At the close of the 2022 financial year, the equity of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) amounts to -179,076 €, a solvency of -54.6% of total assets.
How many people work at THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
1.6 full-time equivalents on average according to the 2022 social balance sheet.
Who manages THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
The register lists 1 active mandates at THERACELL ADVANCED BIOTECHNOLOGY (Belgium). Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →